PubMed 37402755

PubMed ID: 37402755

View on PubMed
Generation of the transgene-free canker-resistant Citrus sinensis using Cas12a/crRNA ribonucleoprotein in the T0 generation.
Authors: Su Hang, Wang Yuanchun, Xu Jin, Omar Ahmad A, Grosser Jude W, Calovic Milica, Zhang Liyang, Feng Yu, Vakulskas Christopher A, Wang Nian
Journal: Nature communications (Nat Commun), Vol.14(1), 2023‑Jul‑05

DOI: 10.1006/meth.2001.1262 PMCID: PMC3346182

Abstract
Citrus canker caused by Xanthomonas citri subsp. citri (Xcc) is a destructive citrus disease worldwide. Generating disease-resistant cultivars is the most effective, environmentally friendly and economic approach for disease control. However, citrus traditional breeding is lengthy and laborious. Here, we develop transgene-free canker-resistant Citrus sinensis lines in the T0 generation within 10 months through transformation of embryogenic protoplasts with Cas12a/crRNA ribonucleoprotein to edit the canker susceptibility gene CsLOB1. Among the 39 regenerated lines, 38 are biallelic/homozygous mutants, demonstrating a 97.4% biallelic/homozygous mutation rate. No off-target mutations are detected in the edited lines. Canker resistance of the cslob1-edited lines results from both abolishing canker symptoms and inhibiting Xcc growth. The transgene-free canker-resistant C. sinensis lines have received regulatory approval by USDA APHIS and are exempted from EPA regulation. This study provides a sustainable and efficient citrus canker control solution and presents an efficient transgene-free genome-editing strategy for citrus and other crops.
Publication Types
Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't
Related Articles